Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Congenital Triangular Alopecia is a rare, non-scarring hair loss that can be surgically treated in females for cosmetic reasons.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The 3D scaffold helped maintain hair cell traits and could improve hair loss treatments.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Loss of Fz6 disrupts hair follicle and associated structures' orientation.

Wounds heal without scarring in early development but later result in scars, and studying Wnt signaling could help control scarring.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Finasteride doesn't affect bone density in male rats.